SE401502B - Sett att frasmtella nya substituerade nikotinsyraamider - Google Patents

Sett att frasmtella nya substituerade nikotinsyraamider

Info

Publication number
SE401502B
SE401502B SE7405743A SE7405743A SE401502B SE 401502 B SE401502 B SE 401502B SE 7405743 A SE7405743 A SE 7405743A SE 7405743 A SE7405743 A SE 7405743A SE 401502 B SE401502 B SE 401502B
Authority
SE
Sweden
Prior art keywords
way
acid amides
present new
new substituted
nicotic acid
Prior art date
Application number
SE7405743A
Other languages
English (en)
Swedish (sv)
Inventor
G Regnier
R Canevari
X Pascaud
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE401502B publication Critical patent/SE401502B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7405743A 1973-05-02 1974-04-29 Sett att frasmtella nya substituerade nikotinsyraamider SE401502B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2084273A GB1428493A (en) 1973-05-02 1973-05-02 Heterocyclic amides processes for their preparation and pharma ceutical compositions containing them

Publications (1)

Publication Number Publication Date
SE401502B true SE401502B (sv) 1978-05-16

Family

ID=10152644

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7405743A SE401502B (sv) 1973-05-02 1974-04-29 Sett att frasmtella nya substituerade nikotinsyraamider

Country Status (8)

Country Link
US (1) US3970661A (enExample)
JP (1) JPS523937B2 (enExample)
CA (1) CA1025865A (enExample)
CH (1) CH590234A5 (enExample)
FR (1) FR2227866B1 (enExample)
GB (1) GB1428493A (enExample)
SE (1) SE401502B (enExample)
SU (1) SU576927A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663026B1 (fr) * 1990-06-07 1992-08-07 Synthelabo Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.
FR2684374B1 (fr) * 1991-12-02 1995-05-19 Synthelabo Derives substitues de 1-[(1-arylpyrrolidin-2-yl)methyl]piperazine, leur preparation et leur application en therapeutique.
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
FR2928070A1 (fr) * 2008-02-27 2009-09-04 Sumitomo Chemical Co Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
US20170247326A1 (en) * 2014-09-10 2017-08-31 Epizyme, Inc. Substituted Pyrrolidine Carboxamide Compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105072A (en) * 1963-09-24 Preparation thereof

Also Published As

Publication number Publication date
FR2227866B1 (enExample) 1978-06-30
JPS523937B2 (enExample) 1977-01-31
US3970661A (en) 1976-07-20
SU576927A3 (ru) 1977-10-15
JPS5018472A (enExample) 1975-02-26
FR2227866A1 (enExample) 1974-11-29
GB1428493A (en) 1976-03-17
CA1025865A (fr) 1978-02-07
DE2419535A1 (de) 1974-12-12
DE2419535B2 (de) 1977-01-13
CH590234A5 (enExample) 1977-07-29
AU6842774A (en) 1975-11-06

Similar Documents

Publication Publication Date Title
IT1020070B (it) Acido amminofosfonico ciclico
SE401822B (sv) Sett att framstella nya nonapeptidamidderivat med ovulationsinducerande aktivitet
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE408426B (sv) Sett att framstella d-homo-20-ketopregnaner
SE420725B (sv) Sett att framstella 2,3-dihydro-1-benstiepin-4-karboxylsyraamider
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE7514212L (sv) Sett att framstella nya, antendningshemmande verksamma, substituerade fenylettiksyror
SE401176B (sv) Sett att framstella nya hypokalcemiskt verksamma dotriakontapeptidamider
SE387337B (sv) Sett att framstella nya tiokarbamidsyraderivat
SE404923B (sv) Sett att framstella kristallina prostansyraestrar
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE7603276L (sv) Sett att framstella prostansyraderivat
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE401502B (sv) Sett att frasmtella nya substituerade nikotinsyraamider
SE395896B (sv) Sett att framstella nya 3-acylureidoacetamidopenicillansyraderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE408170B (sv) Sett att framstella nya substituerade nitrobensofenonderivat
SE399712B (sv) Sett att framstella pregnansyraderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE403285B (sv) Sett att framstella nya 1,4-dihydrokinoliner
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner